{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:14:45Z","timestamp":1793229285716,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Alzheimer's disease (AD) is a progressive, neurodegenerative disease that creates complex challenges and a significant burden for patients and caregivers. Although underlying pathological changes due to AD may be detected in research studies decades prior to symptom onset, many patients in the early stages of AD remain undiagnosed in clinical practice. Increasing evidence points to the importance of an early and accurate AD diagnosis to optimize outcomes for patients and their families, yet many barriers remain along the diagnostic journey. Through a series of international working group meetings, a diverse group of experts contributed their perspectives to create a blueprint for a patient-centered diagnostic journey for individuals in the early stages of AD and an evolving, transdisciplinary care team. Here, we discuss key learnings, implications, and recommendations.<\/jats:p>","DOI":"10.3389\/fneur.2020.592302","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T20:59:13Z","timestamp":1611349153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management"],"prefix":"10.3389","volume":"11","author":[{"given":"James E.","family":"Galvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Langbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stefanacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Vassey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"de Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neva","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.12068","article-title":"2020 Alzheimer's disease facts and figures","volume":"16","author":"Alzheimer's","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B4","unstructured":"The Gerontological Society of America Workgroup on Cognitive Impairment Detection and Earlier Diagnosis: Report and Recommendations"},{"key":"B5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer's disease facts and figures","volume":"15","author":"Alzheimer's","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.7326\/0003-4819-145-10-200611210-00004","article-title":"The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial","volume":"145","author":"Vickrey","year":"2006","journal-title":"Ann Intern Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0891988719856690","article-title":"Nonpharmacological interventions to improve depression, anxiety, and quality of life (qol) in people with dementia: an overview of systematic reviews","volume":"33","author":"Kishita","year":"2020","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1590\/S1980-5764-2016DN1003003","article-title":"Effects of cognitive stimulation on neuropsychiatric symptoms in elderly with Alzheimer's disease: a systematic review","volume":"10","author":"Fukushima","year":"2016","journal-title":"Dement Neuropsychol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.arr.2015.11.005","article-title":"The effect of physical activity on cognitive function in patients with dementia: a meta-analysis of randomized control trials","volume":"25","author":"Groot","year":"2016","journal-title":"Ageing Res Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer's disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fneur.2018.01179","article-title":"Alzheimer's \u201cprevention\u201d vs","volume":"9","author":"Hodes","year":"2018","journal-title":"Front Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2040622317712442","article-title":"Strategies for dementia prevention: latest evidence and implications","volume":"8","author":"Rakesh","year":"2017","journal-title":"Ther Adv Chronic Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"2015 Alzheimer's disease facts and figures","volume":"11","author":"Alzheimer's","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B14","doi-asserted-by":"crossref","unstructured":"LiuJL\n            HlavkaJP R. H\n            MattkeS.\n          Assessing the Preparedness of the U.S. Health Care System Infrastructure for an Alzheimer's Treatment2017","DOI":"10.7249\/RR2272"},{"key":"B15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jama.2020.0435","article-title":"Screening for cognitive impairment in older adults: US Preventive Services Task Force Recommendation Statement","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2019.22527","article-title":"Issues and questions surrounding screening for cognitive impairment in older patients","volume":"323","author":"Petersen","year":"2020","journal-title":"JAMA."},{"key":"B17","unstructured":"World Alzheimer Report 2018: the State of the Art of Dementia Research; New Frontiers"},{"key":"B18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3233\/JAD-150692","article-title":"Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges","volume":"49","author":"Dubois","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13195-017-0312-4","article-title":"The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease","volume":"9","author":"Ritchie","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1212\/WNL.0b013e318294b1cf","article-title":"Supply and demand analysis of the current and future US neurology workforce","volume":"81","author":"Dall","year":"2013","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/geront\/gnx122","article-title":"The fundamentals of person-centered care for individuals with dementia","volume":"58","author":"Fazio","year":"2018","journal-title":"Gerontologist."},{"key":"B24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2217\/nmt.14.47","article-title":"Collaborative transdisciplinary team approach for dementia care","volume":"4","author":"Galvin","year":"2014","journal-title":"Neurodegener Dis Manag."},{"key":"B25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol."},{"key":"B26","unstructured":"FDA Grants Breakthrough Device Designation for Roche's Elecsys Cerebrospinal Fluid (CSF) Assays to Support the Improved Diagnosis of Alzheimer's disease"},{"key":"B27","unstructured":"C"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41746-019-0084-2","article-title":"Digital biomarkers for Alzheimer's disease: the mobile\/wearable devices opportunity","volume":"2","author":"Kourtis","year":"2019","journal-title":"NPJ Digit Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2017.09.006","article-title":"Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial","volume":"14","author":"Rosenberg","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1037\/ser0000124","article-title":"No wrong door: can clinical care facilitate veteran engagement in housing services?","volume":"14","author":"Johnson","year":"2017","journal-title":"Psychol Serv."},{"key":"B34","doi-asserted-by":"publisher","first-page":"34S","DOI":"10.1177\/0033354918801026","article-title":"The \u201cno wrong door\u201d approach to HIV testing: results from a statewide retail pharmacy-based HIV testing program in Virginia, 2014-2016","volume":"133","author":"Collins","year":"2018","journal-title":"Public Health Rep."},{"key":"B35","volume-title":"Global Action Plan on the Public Health Response to Dementia 2017\u20132025","year":"2017"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.592302\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T20:59:26Z","timestamp":1611349166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.592302\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":35,"alternative-id":["10.3389\/fneur.2020.592302"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.592302","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"article-number":"592302"}}